Ardelyx reported $102.27M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.6B 330M Jun/2026
Amgen USD 1.72B 134M Jun/2026
Ardelyx USD 102.27M 26.35M Mar/2026
aTyr Pharma USD 700.63K 81.56M Mar/2026
Corcept Therapeutics USD 156.9M 28.85M Jun/2026
Curis USD 2.96M 1.62M Mar/2026
Sanofi EUR 2.49B 252M Mar/2026
TG Therapeutics USD 62.32M 10.82M Jun/2026
United Therapeutics USD 206.7M 50.1M Jun/2026